A clinical evaluation of dibistine: a combination of two antihistamines.
D018926:Anti-Allergic Agents; D006633:Histamine Antagonists; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000628:therapy*; D014309:Tripelennamine / Q000627:therapeutic use*
D018926:Anti-Allergic Agents; D006633:Histamine Antagonists; D006634:Histamine H1 Antagonists; D014309:Tripelennamine
ALLERGY/therapy; ANTIHISTAMINICS/therapeutic use; TRIPELENNAMINE/therapeutic use